Effect of pH on the antimicrobial susceptibility of planktonic and biofilm-grown clinical Pseudomonas aeruginosa isolates

British Journal of Biomedical Science

Volumn 64, Issue 3, 2007, Pages 101-104

  Moriarty, T F ^a   Elborn, J S ^a   Tunney, M M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Ceftazidime; Cystic fibrosis; pH; Pseudomonas aeruginosa; Tobramycin

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOFILM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFECT; GRAM NEGATIVE INFECTION; HUMAN; NONHUMAN; PH MEASUREMENT; PLANKTON; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

PSEUDOMONAS AERUGINOSA;

EID: 34748845101     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2007.11732766     Document Type: Article

References (16)

1. Smith AL, Fiel SB, Mayer-Hamblett N et al. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 2003; 123 (5): 1495-502.
2. Johnson CC, Livornese L, Gold MJ et al. Activity of cefepime against ceftazidime-resistant Gram-negative bacilli using low and high inocula. J Antimicrob Chemother 1995; 35 (6): 765-73.
3. Singh PK, Schaefer AL, Parsek MR et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000; 407 (6805): 762-4.
4. Smith JJ, Welsh MJ. cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Invest 1992; 89 (4): 1148-53.
5. Tate S, MacGregor G, Davis M et al. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 2002; 57 (11): 926-9.
6. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 (Suppl 1): 5-16.
7. Lam J, Chan R, Lam K, Costerton JW. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980; 28 (2): 546-56.
8. Gudmundsson A, Erlendsdottir H, Gottfredsson M, Gudmundsson S. Impact of pH and cationic supplementation on in vitro post-antibiotic effect. Antimicrob Agents Chemother 1991; 35 (12): 2617-24.
9. Garrison MW, Malone CL, Eiland J, Anderson DE. Influence of pH on the antimicrobial activity of clarithromycin and 14-hydroxyclarithromycin against Haemophilus influenzae using an in vitro pharmacodynamic model. Diagn Microbiol Infect Dis 1997; 27 (4): 139-45.
10. Damper PD, Epstein W. Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics. Antimicrob Agents Chemother 1981; 20 (6): 803-8.
11. Moriarty TF, McElnay JC, Tunney MM, Elborn JS. Intrapulmonary concentrations of tobramycin and ceftazidime achieved after intravenous administration for the treatment of cystic fibrosis lung infections. J Cystic Fibrosis 2006; 5 (Suppl 1): S20.
12. Aaron SD, Ferris W, Ramotar K et al. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J Clin Microbiol 2002; 40 (11): 4172-9.
13. Brooun A, Liu S, Lewis K. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2000; 44 (3): 640-6.
14. Abdi-Ali A, Mohammadi-Mehr M, Agha Alaei Y. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. Int J Antimicrob Agents 2006; 27 (3): 196-200.
15. Harrison JJ, Turner RJ, Ceri H. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Environ Microbiol 2005; 7 (7): 981-94.
16. Hunter RC, Beveridge TJ. Application of a pH-sensitive fluoroprobe (C-SNARF-4) for pH microenvironment analysis in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2005; 71 (5): 2501-10.